19 results
Acute Ischemic Stroke Management

 • Initial Assessment
 • BP/Temp/BG
 • IV Alteplase
 • Tx of ICB
Ischemic Stroke Management ... BP/Temp/BG • IV ... Ischemic #Stroke #Management ... #CVA #neurology
Lupus Nephritis Primer
Class I - Minimal Mesangial
Class II - Mesangial Proliferative
Class Ill - Focal Proliferative
Class IV
Lupus Nephritis ... Proliferative Class IV ... DrFlashHeart #Lupus ... differential #diagnosis #management ... #nephrology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS
Management of Lupus Nephritis
Lupus nephritis (LN) in 10 to 40% of SLE
Hallmark = proteinuria 20.5 g/g
Management of Lupus ... Nephritis Lupus ... BaillouChloe #Lupus ... #Nephritis #Management ... #rheumatology #nephrology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... to 5 mg/kg/day IV ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS
Treatment Algorithm for Active Proliferative Lupus Nephritis (Class III/IV or Mixed Class III/IV + V)
Induction Therapy
Proliferative Lupus ... (Euro-Lupus) 500 ... Proliferative #Lupus ... #Nephritis #management ... #nephrology
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Manifestations of Systemic Lupus ... Diagnosis of Lupus ... prevention (statin for CVA ... Erythematosus #SLE #CNS #neurology ... cerebritis #diagnosis #management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection General Management ... IsosporaBelli #IDSA ... #opportunistic ... #infections #HIVAIDS